Skip to main content
Top
Published in: Journal of Gastroenterology 9/2003

01-09-2003

Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens

Authors: Kyoichi Adachi, Yoshinori Komazawa, Hirofumi Fujishiro, Takafumi Mihara, Masahiro Ono, Mika Yuki, Akira Kawamura, Mohammad Azharul Karim Rumi, Yuji Amano, Yoshikazu Kinoshita

Published in: Journal of Gastroenterology | Issue 9/2003

Login to get access
Metadata
Title
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens
Authors
Kyoichi Adachi
Yoshinori Komazawa
Hirofumi Fujishiro
Takafumi Mihara
Masahiro Ono
Mika Yuki
Akira Kawamura
Mohammad Azharul Karim Rumi
Yuji Amano
Yoshikazu Kinoshita
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 9/2003
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-003-1157-0

Other articles of this Issue 9/2003

Journal of Gastroenterology 9/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine